A Phase 3, Randomized, Double-Blind, Adaptive, Placebo/Paclitaxel-Controlled Study of AVB-S6-500 in Combination with Paclitaxel in Patients with Platinum-Resistant Recurrent Ovarian Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
GOG Foundation
Start Date
September 1, 2021
End Date
September 14, 2026
Administered By
Duke Cancer Institute
Awarded By
GOG Foundation
Start Date
September 1, 2021
End Date
September 14, 2026